Across health care, clinicians are increasingly using patient-reported outcome measures (PROMs) to give a voice to patients and to help standardize the assessment of patients for comparison purposes. With this increasing use, the limitations of these PROMs should not be underestimated within the diverse population that we treat.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Beutel, M. E. et al. Sexual activity, sexual and partnership satisfaction in ageing men — results from a German representative community study. Andrologia 34, 22–28 (2002).
Rosen, R. C. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49, 822–830 (1997).
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M. & Sanda, M. G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56, 899–905 (2000).
Institute of Medicine (US) Committee on Lesbian, Gay, Bisexual, and Transgender Health Issues and Research Gaps and Opportunities. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding (National Academies Press, 2011).
Meyer, I. H. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol. Bull. 129, 674–697 (2003).
Rosser, B. R. S. et al. Understanding prostate cancer in gay, bisexual, and other men who have sex with men and transgender women: a review of the literature. Curr. Sex. Health Rep. 11, 430–441 (2019).
Hoyt, M. A. et al. Gay men’s experiences with prostate cancer: implications for future research. J. Health Psychol. 25, 298–310 (2020).
Polter, E. J. et al. Creation and psychometric validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in sexual minority patients-the Restore-2 study. J. Sex. Med. 19, 529–540 (2022).
Kinnaird, W. et al. The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy to treat prostate cancer: a comparison of uro-oncology practice according to disease stage. Int. J. Clin. Pract. 75, e13873 (2021).
Rosser, B. R. S. et al. Acceptability and feasibility of collecting sexual orientation and expanded gender identity data in urology and oncology clinics. LGBT Health 8, 420–426 (2021).
F.M., M.S. and A.S. have received an unrestricted education grant from Boston Scientific. T.Y. declares no competing interests.
British Association for Sexual Health and HIV: https://www.bashhguidelines.org/current-guidelines/sexual-history-taking-sti-testing-and-specific-groups/sexual-history-taking-2019/
About this article
Cite this article
MacAskill, F., Sahai, A., Shabbir, M. et al. Is it time to rethink the current patient-reported outcome measures?. Nat Rev Urol (2022). https://doi.org/10.1038/s41585-022-00661-7